\-\ Texto\\:\\ \ \(0\)\
\-\ a\\ well\\-developed\\ in\\ no\\ acute\\ distress\\.\\ \\ \ \(0\)\
\-\ there\\ is\\ no\\ adenopathy\\ noted\\ in\\ the\\ cervical\\,\\ supraclavicular\\,\\ or\\ axillary\\ areas\\.\\ \\ \ \(0\)\
\-\ lungs\\ are\\ clear\\.\\ \\ heart\\:\\ \\ regular\\ rate\\ and\\ rhythm\\.\\ \\ there\\ are\\ no\\ masses\\,\\ tenderness\\,\\ or\\ discharge\\ noted\\ on\\ the\\ reconstructed\\ left\\ breast\\ nor\\ in\\ the\\ right\\ breast\\.\\ abdomen\\:\\ \\ normoactive\\ bowel\\ sounds\\.\\ \\ soft\\,\\ nontender\\,\\ nondistended\\ without\\ any\\ hepatosplenomegaly\\.\\ \\ there\\ is\\ no\\ inguinal\\ adenopathy\\.\\ \\ extremities\\:\\ \\ without\\ clubbing\\,\\ cyanosis\\,\\ or\\ edema\\.\\ \\ neuro\\:\\ \\ cranial\\ nerves\\ ii\\ through\\ xii\\ are\\ intact\\,\\ otherwise\\,\\ is\\ nonfocal\\.\ \(0\)\
\-\ the\\ patient\\ will\\ be\\ followed\\ up\\ by\\ interventional\\ radiology\\ for\\ splenic\\ artery\\ embolization\\ because\\ of\\ the\\ risk\\ of\\ rupture\\ which\\ carries\\ a\\ high\\ mortality\\ rate\\.\ \(0\)\
\-\ contrast\\ enhanced\\ biphasic\\ ct\\ scan\\ of\\ the\\ abdomen\\ shows\\ a\\ well\\ circumscribed\\ lesion\\ in\\ the\\ head\\/body\\ of\\ the\\ pancreas\\ that\\ is\\ highly\\ attenuated\\ in\\ the\\ arterial\\ phase\\.\\ the\\ lesion\\ measures\\ 3\\.8\\ x\\ 3\\.5\\ cm\\ which\\ has\\ not\\ significantly\\ changed\\ in\\ size\\ when\\ compared\\ to\\ pet\\/ct\\ scans\\ dated\\ 10\\/29\\/2010\\ and\\ 6\\/23\\/2010\\,\\ done\\ at\\ an\\ outside\\ facility\\.\\ there\\ are\\ \\ feeding\\ and\\ draining\\ vessel\\ in\\ close\\ proximity\\ posteriorly\\.\\ this\\ enhancing\\ lesion\\ represents\\ a\\ splenic\\ artery\\ aneurysm\\ in\\ the\\ middle\\ region\\ of\\ the\\ splenic\\ artery\\ located\\ in\\ the\\ body\\ of\\ the\\ pancreas\\.\\ \\ pre\\-contrast\\ study\\ reveals\\ no\\ significant\\ calcification\\ in\\ the\\ vessel\\ walls\\.\ \(0\)\
\-\ splenic\\ artery\\ aneurysm\ \(6\)\
\-\ \\â\\€\\¢\\ splenic\\ artery\\ aneurysm\ \(1\)\
\-\ \\â\\€\\¢\\ pancreatic\\ pseudocyst\ \(1\)\
\-\ \\â\\€\\¢\\ pseudoaneurysm\ \(1\)\
\-\ this\\ 63\\ y\\.o\\.\\ woman\\ originally\\ presented\\ with\\ breast\\ cancer\\ \\(ductal\\ carcinoma\\-in\\-situ\\)\\ 3\\ yrs\\ ago\\.\ \(0\)\
\-\ this\\ finding\\ of\\ splenic\\ artery\\ aneurysm\\ was\\ an\\ incidental\\ finding\\ during\\ a\\ workup\\ for\\ this\\ patient\\'s\\ metastatic\\ breast\\ cancer\\.\\ the\\ patient\\ was\\ asymptomatic\\ and\\ did\\ not\\ report\\ abdominal\\ pain\\.\\ in\\ addition\\,\\ the\\ mass\\ was\\ not\\ palpated\\/auscultated\\ during\\ the\\ physical\\ exam\\.\\ this\\ is\\ not\\ an\\ uncommon\\ presentation\\ for\\ a\\ splenic\\ artery\\ aneurysm\\ as\\ 90\\%\\ of\\ patients\\ are\\ diagnosed\\ incidentally\\.\ \(0\)\
\-\ regarding\\ her\\ breast\\ cancer\\,\\ 3\\ years\\ ago\\ she\\ had\\ a\\ biopsy\\,\\ which\\ revealed\\ a\\ ductal\\ carcinoma\\ with\\ microinvasive\\ disease\\.\\ \\ she\\ had\\ done\\ well\\ postoperatively\\,\\ until\\ this\\ summer\\ when\\ she\\ palpated\\ a\\ left\\ supraclavicular\\ node\\.\\ \\ she\\ had\\ a\\ biopsy\\ via\\ fna\\,\\ which\\ revealed\\ a\\ metastatic\\ adenocarcinoma\\.\\ \\ her\\ most\\ recent\\ petct\\ from\\ one\\ month\\ ago\\ revealed\\ progression\\ as\\ compared\\ to\\ a\\ previous\\ exam\\ five\\ months\\ earlier\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ splenic\\:\\ 0\\.37844248614100434\ \(0\)\
\-\ artery\\:\\ 0\\.23958257048370515\ \(0\)\
\-\ aneurysm\\:\\ 0\\.20980278011149384\ \(0\)\
\-\ breast\\:\\ 0\\.20009116468526797\ \(0\)\
\-\ the\\:\\ 0\\.19793075861516585\ \(0\)\
\-\ in\\:\\ 0\\.16451063523220344\ \(0\)\
\-\ she\\:\\ 0\\.13121923572839692\ \(0\)\
\-\ ago\\:\\ 0\\.12096521285326907\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.12041470840902696\ \(0\)\
\-\ palpated\\:\\ 0\\.11837898075913206\ \(0\)\
\-\ this\\:\\ 0\\.11361774836525358\ \(0\)\
\-\ cancer\\:\\ 0\\.11011857952614407\ \(0\)\
\-\ revealed\\:\\ 0\\.10840314911130036\ \(0\)\
\-\ are\\:\\ 0\\.1045559485885317\ \(0\)\
\-\ pancreas\\:\\ 0\\.10358896154159469\ \(0\)\
\-\ which\\:\\ 0\\.1002336302587292\ \(0\)\
\-\ ductal\\:\\ 0\\.0969917513892131\ \(0\)\
\-\ vessel\\:\\ 0\\.09667499770175159\ \(0\)\
\-\ adenopathy\\:\\ 0\\.0927122367012553\ \(0\)\
\-\ no\\:\\ 0\\.08960337260749532\ \(0\)\
\-\ compared\\:\\ 0\\.08910438598334133\ \(0\)\
\-\ microinvasive\\:\\ 0\\.08813057415691805\ \(0\)\
\-\ petct\\:\\ 0\\.08813057415691805\ \(0\)\
\-\ there\\:\\ 0\\.08771008958316946\ \(0\)\
\-\ done\\:\\ 0\\.08767250567173653\ \(0\)\
\-\ not\\:\\ 0\\.08702218405123228\ \(0\)\
\-\ of\\:\\ 0\\.08627599992764852\ \(0\)\
\-\ rate\\:\\ 0\\.08351940231098744\ \(0\)\
\-\ had\\:\\ 0\\.0823713225823685\ \(0\)\
\-\ summer\\:\\ 0\\.08143423790560744\ \(0\)\
\-\ well\\:\\ 0\\.08005149975073972\ \(0\)\
\-\ dated\\:\\ 0\\.07927849913349785\ \(0\)\
\-\ lesion\\:\\ 0\\.07926079936671615\ \(0\)\
\-\ biphasic\\:\\ 0\\.07751713230637107\ \(0\)\
\-\ biopsy\\:\\ 0\\.0772582620351393\ \(0\)\
\-\ is\\:\\ 0\\.07545925887091424\ \(0\)\
\-\ nonfocal\\:\\ 0\\.07258216288218725\ \(0\)\
\-\ body\\:\\ 0\\.07253712514098563\ \(0\)\
\-\ finding\\:\\ 0\\.07244725734081674\ \(0\)\
\-\ postoperatively\\:\\ 0\\.07082079605506046\ \(0\)\
\-\ during\\:\\ 0\\.06981126905065652\ \(0\)\
\-\ her\\:\\ 0\\.06885739608388151\ \(0\)\
\-\ reconstructed\\:\\ 0\\.06804156540298624\ \(0\)\
\-\ carries\\:\\ 0\\.06804156540298624\ \(0\)\
\-\ attenuated\\:\\ 0\\.06745588480847897\ \(0\)\
\-\ abdomen\\:\\ 0\\.0672508027328915\ \(0\)\
\-\ normoactive\\:\\ 0\\.06690369045582407\ \(0\)\
\-\ when\\:\\ 0\\.06657751014283182\ \(0\)\
\-\ carcinoma\\:\\ 0\\.06592689169601286\ \(0\)\
\-\ proximity\\:\\ 0\\.06541447602281208\ \(0\)\
\-\ fna\\:\\ 0\\.06453561849683458\ \(0\)\
\-\ hepatosplenomegaly\\:\\ 0\\.06373008785876703\ \(0\)\
\-\ an\\:\\ 0\\.06321997758054504\ \(0\)\
\-\ nondistended\\:\\ 0\\.06263524537073786\ \(0\)\
\-\ pseudocyst\\:\\ 0\\.06263524537073786\ \(0\)\
\-\ changed\\:\\ 0\\.061651946058875785\ \(0\)\
\-\ yrs\\:\\ 0\\.06134522915167564\ \(0\)\
\-\ metastatic\\:\\ 0\\.06044856962829321\ \(0\)\
\-\ clubbing\\:\\ 0\\.06020735420451348\ \(0\)\
\-\ pseudoaneurysm\\:\\ 0\\.05918949037956603\ \(0\)\
\-\ interventional\\:\\ 0\\.05871813977150147\ \(0\)\
\-\ xii\\:\\ 0\\.058490817022107955\ \(0\)\
\-\ noted\\:\\ 0\\.05843694870916589\ \(0\)\
\-\ without\\:\\ 0\\.05813538005570013\ \(0\)\
\-\ regarding\\:\\ 0\\.057839282245523975\ \(0\)\
\-\ was\\:\\ 0\\.05761762944802289\ \(0\)\
\-\ or\\:\\ 0\\.05751385339930927\ \(0\)\
\-\ cyanosis\\:\\ 0\\.05722892533848948\ \(0\)\
\-\ originally\\:\\ 0\\.05611298177668679\ \(0\)\
\-\ inguinal\\:\\ 0\\.05559989991106732\ \(0\)\
\-\ exam\\:\\ 0\\.05548334675591053\ \(0\)\
\-\ facility\\:\\ 0\\.05464889290036503\ \(0\)\
\-\ axillary\\:\\ 0\\.05420633745848288\ \(0\)\
\-\ mortality\\:\\ 0\\.05420633745848288\ \(0\)\
\-\ patient\\:\\ 0\\.05377213779014709\ \(0\)\
\-\ nor\\:\\ 0\\.05364613583549649\ \(0\)\
\-\ contrast\\:\\ 0\\.05355224190693848\ \(0\)\
\-\ draining\\:\\ 0\\.05337776382534772\ \(0\)\
\-\ 63\\:\\ 0\\.053246322735144874\ \(0\)\
\-\ rhythm\\:\\ 0\\.05225460445011218\ \(0\)\
\-\ nontender\\:\\ 0\\.05190747353374815\ \(0\)\
\-\ workup\\:\\ 0\\.05190747353374815\ \(0\)\
\-\ significantly\\:\\ 0\\.051794480770797346\ \(0\)\
\-\ feeding\\:\\ 0\\.05168279431183095\ \(0\)\
\-\ walls\\:\\ 0\\.05168279431183095\ \(0\)\
\-\ nerves\\:\\ 0\\.05146322188062437\ \(0\)\
\-\ neuro\\:\\ 0\\.05135527918109326\ \(0\)\
\-\ progression\\:\\ 0\\.05053258908717887\ \(0\)\
\-\ earlier\\:\\ 0\\.05033741535614582\ \(0\)\
\-\ for\\:\\ 0\\.050108938843842606\ \(0\)\
\-\ pancreatic\\:\\ 0\\.04995851302391905\ \(0\)\
\-\ close\\:\\ 0\\.04986606474808126\ \(0\)\
\-\ uncommon\\:\\ 0\\.04986606474808126\ \(0\)\
\-\ five\\:\\ 0\\.04977449277240298\ \(0\)\
\-\ discharge\\:\\ 0\\.04941664552537618\ \(0\)\
\-\ highly\\:\\ 0\\.04932921713590849\ \(0\)\
\-\ represents\\:\\ 0\\.049242572868116646\ \(0\)\
\-\ posteriorly\\:\\ 0\\.048576048529019034\ \(0\)\
\-\ embolization\\:\\ 0\\.0480283277912169\ \(0\)\
\-\ scans\\:\\ 0\\.04795255664905443\ \(0\)\
\-\ regular\\:\\ 0\\.047582366872147064\ \(0\)\
\-\ node\\:\\ 0\\.047366876054547154\ \(0\)\
\-\ phase\\:\\ 0\\.047156087232006226\ \(0\)\
\-\ incidentally\\:\\ 0\\.04694979958418588\ \(0\)\
\-\ report\\:\\ 0\\.04642030975690943\ \(0\)\
\-\ until\\:\\ 0\\.04585738717316659\ \(0\)\
\-\ and\\:\\ 0\\.04555003152765381\ \(0\)\
\-\ arterial\\:\\ 0\\.04538314368557694\ \(0\)\
\-\ cranial\\:\\ 0\\.045042139892487745\ \(0\)\
\-\ via\\:\\ 0\\.045042139892487745\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.045042139892487745\ \(0\)\
\-\ measures\\:\\ 0\\.044931095323897434\ \(0\)\
\-\ addition\\:\\ 0\\.04460542051531065\ \(0\)\
\-\ rupture\\:\\ 0\\.04455219299167067\ \(0\)\
\-\ distress\\:\\ 0\\.04439424771172466\ \(0\)\
\-\ as\\:\\ 0\\.04427812350039559\ \(0\)\
\-\ outside\\:\\ 0\\.04423884321699274\ \(0\)\
\-\ radiology\\:\\ 0\\.04413661188097524\ \(0\)\
\-\ 90\\:\\ 0\\.044035451049818035\ \(0\)\
\-\ located\\:\\ 0\\.04359289560793588\ \(0\)\
\-\ ii\\:\\ 0\\.04344977045531077\ \(0\)\
\-\ circumscribed\\:\\ 0\\.04267649617810117\ \(0\)\
\-\ sounds\\:\\ 0\\.04254623661680604\ \(0\)\
\-\ ct\\:\\ 0\\.041960687414704254\ \(0\)\
\-\ enhanced\\:\\ 0\\.04196055602229877\ \(0\)\
\-\ reveals\\:\\ 0\\.04192004958517047\ \(0\)\
\-\ extremities\\:\\ 0\\.04187971227770844\ \(0\)\
\-\ previous\\:\\ 0\\.041641162599565185\ \(0\)\
\-\ incidental\\:\\ 0\\.04084978003007738\ \(0\)\
\-\ lungs\\:\\ 0\\.040670539803236545\ \(0\)\
\-\ clear\\:\\ 0\\.0399520630132849\ \(0\)\
\-\ diagnosed\\:\\ 0\\.039919147236631876\ \(0\)\
\-\ intact\\:\\ 0\\.039886343228535785\ \(0\)\
\-\ did\\:\\ 0\\.03953266485607437\ \(0\)\
\-\ cervical\\:\\ 0\\.03946972801392679\ \(0\)\
\-\ middle\\:\\ 0\\.03940719853283436\ \(0\)\
\-\ risk\\:\\ 0\\.03937608491140987\ \(0\)\
\-\ calcification\\:\\ 0\\.03934507117337206\ \(0\)\
\-\ otherwise\\:\\ 0\\.03928334079655253\ \(0\)\
\-\ because\\:\\ 0\\.038514801031126936\ \(0\)\
\-\ heart\\:\\ 0\\.03831792260854427\ \(0\)\
\-\ presentation\\:\\ 0\\.03793580840580466\ \(0\)\
\-\ left\\:\\ 0\\.03759745900908001\ \(0\)\
\-\ masses\\:\\ 0\\.03751684753200014\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.03751684753200014\ \(0\)\
\-\ areas\\:\\ 0\\.03741488594066991\ \(0\)\
\-\ size\\:\\ 0\\.03731398924181719\ \(0\)\
\-\ recent\\:\\ 0\\.03731398924181719\ \(0\)\
\-\ followed\\:\\ 0\\.03721413542156666\ \(0\)\
\-\ study\\:\\ 0\\.03675343420400016\ \(0\)\
\-\ any\\:\\ 0\\.035615559256838\ \(0\)\
\-\ will\\:\\ 0\\.035469339389415\ \(0\)\
\-\ bowel\\:\\ 0\\.03536623519731615\ \(0\)\
\-\ tenderness\\:\\ 0\\.03455988414643321\ \(0\)\
\-\ enhancing\\:\\ 0\\.034522220273768965\ \(0\)\
\-\ years\\:\\ 0\\.033780805861177675\ \(0\)\
\-\ month\\:\\ 0\\.03352317003042825\ \(0\)\
\-\ region\\:\\ 0\\.03296344584800643\ \(0\)\
\-\ edema\\:\\ 0\\.03286795145166354\ \(0\)\
\-\ through\\:\\ 0\\.03280480893209923\ \(0\)\
\-\ scan\\:\\ 0\\.0326952929451936\ \(0\)\
\-\ shows\\:\\ 0\\.032343953459343766\ \(0\)\
\-\ presented\\:\\ 0\\.03213618693343375\ \(0\)\
\-\ months\\:\\ 0\\.03207763662632571\ \(0\)\
\-\ significant\\:\\ 0\\.031818464779816334\ \(0\)\
\-\ cm\\:\\ 0\\.03164946738986653\ \(0\)\
\-\ one\\:\\ 0\\.03155223379017862\ \(0\)\
\-\ high\\:\\ 0\\.03132009101818255\ \(0\)\
\-\ patients\\:\\ 0\\.031001575209103453\ \(0\)\
\-\ abdominal\\:\\ 0\\.030140329726238254\ \(0\)\
\-\ physical\\:\\ 0\\.029881122757379055\ \(0\)\
\-\ acute\\:\\ 0\\.029811620507234807\ \(0\)\
\-\ soft\\:\\ 0\\.029338621162737905\ \(0\)\
\-\ woman\\:\\ 0\\.028700714828918634\ \(0\)\
\-\ most\\:\\ 0\\.02868015998903274\ \(0\)\
\-\ to\\:\\ 0\\.027554060232766495\ \(0\)\
\-\ up\\:\\ 0\\.02726012483263131\ \(0\)\
\-\ has\\:\\ 0\\.02517198149406473\ \(0\)\
\-\ that\\:\\ 0\\.023915045547088783\ \(0\)\
\-\ by\\:\\ 0\\.023402287953658413\ \(0\)\
\-\ disease\\:\\ 0\\.023132612997972875\ \(0\)\
\-\ be\\:\\ 0\\.022355337020560303\ \(0\)\
\-\ from\\:\\ 0\\.021886781076152027\ \(0\)\
\-\ with\\:\\ 0\\.021581887454261713\ \(0\)\
\-\ mass\\:\\ 0\\.021049996288105537\ \(0\)\
\-\ at\\:\\ 0\\.020815198299551408\ \(0\)\
\-\ pain\\:\\ 0\\.019719868496780174\ \(0\)\
\-\ right\\:\\ 0\\.01827076563603132\ \(0\)\
\-\ on\\:\\ 0\\.016643729069478554\ \(0\)\
